Skip to main content
OpenTrials

Clinical trial condition

Relapsed Angioimmunoblastic T-Cell Lymphoma

Explore clinical trials studying Relapsed Angioimmunoblastic T-Cell Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Relapsed Angioimmunoblastic T-Cell Lymphoma trial results

Completed

Efficacy and Safety of Oral Azacitidine Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory AITL

NCT03593018

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoblastic Lymphadenopathy, +6 more
Locations
  • University Hospital for Internal Medicine - University Hospital Graz Graz, Austria
  • Medical University of Vienna Vienna, Austria
  • A. Z. Sint-Jan Brugge-Oostende AV Bruges, Belgium
  • Cliniques Universitaires de Bruxelles - Hôpital Erasme Brussels, Belgium
View all 27 locations
View Trial Details

Related conditions